Neurocrine Biosciences NBIX
NASDAQ NBIX
$140.71 -1.13 (-0.80%)
At close: Oct 1, 2026 · 4:00 PM EDT

Neurocrine Biosciences (NBIX) Prepaid Assets (2024 - 2026)

Updated

Neurocrine Biosciences (NBIX) recorded Prepaid Assets of $217.1 million in Q2 2026, down 3.4% from the prior quarter.

Analysis

Neurocrine Biosciences (NBIX) Prepaid Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Neurocrine Biosciences reported Prepaid Assets of $170.7 million, up 252.0% from FY2024.

  • Across earlier years, Prepaid Assets came in at $48.5 million in FY2024.
  • Quarterly Prepaid Assets has ranged from $48.5 million in Q4 2024 to $224.8 million in Q1 2026 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $224.8 million (Q1 2026), $170.7 million (Q4 2025) and $178.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Neurocrine Biosciences 14.41 Bn 10.11 Bn 935.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 217.10 Mn
Mar 31, 2026 224.80 Mn
Dec 31, 2025 170.70 Mn
Sep 30, 2025 178.10 Mn
Dec 31, 2024 48.50 Mn
API Access

Neurocrine Biosciences Prepaid Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=prepaid-assets&ticker=NBIX&period=max&api_key=YOUR_API_KEY